our youngsters 2016 Drug Trend: PBM Clients Achieved Lowest Prescription Drug Trend in Four Years, Despite Rising Drug Prices people searching for products/services

high quality 2016 Drug Trend: PBM Clients Achieved Lowest Prescription Drug Trend in Four Years, Despite Rising Drug Prices wind up
 
Photo :2016 Drug Trend: PBM Clients Achieved Lowest Prescription Drug Trend in Four Years, Despite Rising Drug Prices

uniqueness 03.15.17 At a time when the cost of prescription drugs continues to draw widespread attention and scrutiny, prescription drug trend for our CVS Caremark pharmacy benefit management (PBM) clients dropped to an average of 3.2 percent in 2016 as compared to 5.0 percent in 2015. In addition, 38 percent of our clients achieved negative trend which means they actually spent less on their prescription benefit in 2016 than they did in 2015, and out-of-pocket costs for members also dropped 3.0 percent compared to the previous year. "No one is more concerned about the high cost of prescription drugs than CVS Health," said Troyen Brennan, M.D., Executive Vice President and Chief Medical Officer, CVS Health. Our very favorable drug trend results for 2016 demonstrate that we have been able to deliver best-in-class value to our clients and their members. In the full report , we explore the factors that helped drive down prescription drug trend, a measure of growth in prescription spending, to a four year low. In fact, CVS Caremark was able to reduce trend for clients by 7.8 percentage points to 3.2 percent through PBM management solutions that include price protection and the negotiation of rebates, of which more than 90 percent are passed back to clients. In addition, generic drugs continue to be a moderating force on drug trend and also help keep costs low for members. Without these strategies in place, prescription drug trend would have risen by 11.0 percent for our clients, driven primarily by price inflation for branded specialty and traditional drugs, as well as increased utilization due to an aging population, which underscores the vital role that PBMs play in the health care system. Related Articles U.S. Health Care Evolution & Outlook: Merlo at Economic Club of New York CVS Health President & CEO Larry Merlo sits down with Fortune senior correspondent Susie Gharib to discuss important health care topics. Tax Reform: Supporting Growth, Creating Jobs and Investing in Better Health Comprehensive tax reform will strengthen our company s ability to help lower health care costs and improve patient outcomes. Project Health: Helping People on Their Path to Better Health Project Health helps ensure that cost isn t a barrier to services in communities with a large number of uninsured or underinsured Americans. Related Press Releases 05.02.17 CVS Health Lauds New Research Showing that Limiting Pharmaceutical Detailing Can Impact Prescribing Behavior 03.15.17 CVS Health PBM Clients Achieved Lowest Prescription Drug Trend in Four Years, Despite Rising Drug Prices 01.12.17 CVS Health Offers Patients Lowest Cash Price in the Market for Generic Epinephrine Auto-injector to Treat Allergic Reactions 06.16.16 CVS Health CEO Larry Merlo Keynotes at 2016 AHIP Institute and Expo 05.04.16 CVS Health Research Institute Study Shows that Home Infusion Care Improves Patient Outcomes and Quality of Life While Reducing Overall Costs 02.23.16 CVS Health Reports Dramatic Drop in Prescription Drug Trend to 5 Percent, Despite Rising Drug Prices instantly


searching for 2016 Drug Trend: PBM Clients Achieved Lowest Prescription Drug Trend in Four Years, Despite Rising Drug Prices take the plunge


EmoticonEmoticon